Follow us...


Search News Archives





View Channel

Laboratory Products



View Channel

Special Offers and Promotions


Microscopy | Image Analysis



View Channel

Separation Science



View Channel

Coronavirus (COVID-19)



View Channel

Research & Case Studies



View Channel

Conferences | Events




Contact bioMérieux

If you have not logged into the website then please enter your details below.

All articles from bioMérieux

  Differential diagnosis of Plasmodium falciparum with bioMérieux’s new VIKIA Malaria Ag Pf/Pan rapid test

bioMérieux has further extended its range of rapid tests for infectious diseases with the launch of VIKIA Malaria Ag Pf/Pan.

VIKIA® Malaria Ag Pf/PanThis qualitative immunochromatographic test differentiates between Plasmodium falciparum and other less virulent malarial species, enabling rapid, effective diagnosis and allowing swift initiation of the appropriate treatment. The VIKIA Malaria Ag Pf/Pan test is an easy-to-use lateral flow assay that enables malarial infections to be detected in whole blood specimens in just 20 minutes, without the need for any additional equipment or specific training....


  North Bristol NHS Trust invests in bioMérieux’s BacT/ALERT bioMérieux BacT/ALERT®North Bristol NHS Trust recently chose to award their tender for Pathology Managed Equipment & Consumables Services to Roche Diagnostics Ltd. As part of that tender bioMérieux UK Ltd were chosen to provide a range of automation as part of the Microbiology solution. This included the BacT/ALERT 3D system for both Southmead and Frenchay hospitals, simplifying the integration of the two laboratories.


  bioMérieux Awarded NHSBT Contract for Bacterial Screening of Platelets bioMérieux, a world leader in the field of in vitro diagnostics was chosen by National Health Service Blood and Transplant (NHSBT) for bacterial screening of platelets in England and North Wales. During an extensive tender process, a number of technologies for screening platelet products were evaluated and bioMérieux' s BacT/ALERT® 3D for bacterial screening has been chosen.


  bioMérieux launches new chromID MRSA medium bioMérieux has recently launched a new version of chromIDTM MRSA chromogenic medium for the detection of methicillin resistant Staphylococcus aureus (MRSA), providing a cost effective solution for rapid routine screening.



Media Partners